DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Brompheniramine Maleate is a drug marketed by Alpharma Us Pharms, Kv Pharm, Pharm Assoc, Usl Pharma, Watson Labs, Barr, Ivax Sub Teva Pharms, Newtron Pharms, Nexgen Pharma Inc, Par Pharm, Pioneer Pharms, Upsher Smith Labs, Vitarine, Acella, Alkem Labs Ltd, Lannett Co Inc, Mayne Pharma Inc, Paddock Labs Llc, Taro, and Wes Pharma Inc. and is included in twenty-four NDAs.
The generic ingredient in BROMPHENIRAMINE MALEATE is brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride profile page.
Recent Clinical Trials for BROMPHENIRAMINE MALEATE
Identify potential brand extensions & 505(b)(2) entrants
|Ache Laboratorios Farmaceuticos S.A.||Phase 3|
|Wyeth is now a wholly owned subsidiary of Pfizer||N/A|